Recent advances in combinatorial chemistry applied to development of anti-HIV drugs

被引：11
|
作者：
Pettersson, S
Clotet-Codina, I
Esté, JA
Borrell, JI
Teixidó, J
机构：
[1] Univ Ramon Llull, IQS, GEM, E-08017 Barcelona, Spain
[2] Univ Autonoma Barcelona, Hosp Univ Germans Trias & Pujol, Lab Retrovirol IrsiCaixa, Badalona 08916, Spain
来源：
MINI-REVIEWS IN MEDICINAL CHEMISTRY | 2006年 / 6卷 / 01期
关键词：
combinatorial chemistry; synthesis; anti-HIV drugs; high throughput screening;
D O I：
10.2174/138955706775197820
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
A compilation of combinatorial chemistry techniques applied to anti-HIV drug development is presented in this review. This synthetic strategy together with high throughput screening assays has allowed the discovery and optimization of novel lead anti-HIV compounds.
引用
收藏
页码：91 / 108
页数：18
相关论文
共 50 条
  • [41] Special Lecture: Transforming anti-HIV drugs
    Gendelman, Howard
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2017, 74 : 68 - 68
  • [42] Targeting strategies for delivery of anti-HIV drugs
    Ramana, Lakshmi Narashimhan
    Anand, Appakkudal R.
    Sethuraman, Swaminathan
    Krishnan, Uma Maheswari
    Journal of Controlled Release, 2014, 192 : 271 - 283
  • [43] CURRENT USE OF ANTI-HIV DRUGS IN AIDS
    CLUMECK, N
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1993, 32 : 133 - 138
  • [44] A new class of anti-HIV drugs debuts
    不详
    AMERICAN JOURNAL OF NURSING, 1996, 96 (07) : 59 - &
  • [45] Secret Transfer of anti-HIV drugs to Africa
    不详
    ETHIK IN DER MEDIZIN, 2012, 24 (01) : 57 - 58
  • [46] Asymmetric biosynthesis of intermediates of anti-HIV drugs
    Wang, Yiyuan
    Cao, Yingxiu
    Li, Yuanxiu
    Jin, Jiayu
    Li, Jinliang
    Song, Hao
    TETRAHEDRON-ASYMMETRY, 2017, 28 (06) : 745 - 757
  • [47] Proposed alternatives for the use of anti-HIV drugs
    Berkhout, B
    DRUG RESISTANCE UPDATES, 1999, 2 (01) : 69 - 70
  • [48] Pharmacodynamics and clinical use of anti-HIV drugs
    Preston, SL
    Piliero, PJ
    Drusano, GL
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2003, 17 (03) : 651 - +
  • [49] New anti-HIV drugs: The place of raltegravir
    Katlama, C.
    Tubiana, R.
    Murphy, R.
    ANTIBIOTIQUES, 2009, 11 (01): : 11 - 17
  • [50] Therapeutic drug monitoring of anti-HIV drugs
    Back, DJ
    Khoo, SH
    Gibbons, SE
    Reynolds, H
    Tjia, JF
    Merry, C
    OPTIMAL DOSE IDENTIFICATION: EXCERTA MEDICA, 2001, 1220 : 145 - 160
12345